Pham-Danis et al. (2019) found that inhibition of the urea cycle enzyme CPS1 synergistically enhanced the suppressing effects of EGFR inhibitor on glycolysis and tumor growth in EGFR-mutant PC9 and HCC4006 cell lines. This evidence concerns the gene EGFR and neoplasm.